HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.

AuthorsMaria Teresa Petrucci, Vincenza Martini, Anna Levi, Cristiano Gallucci, Giovanna Palumbo, Patrizia Del Bianco, Concetta Torromeo, Robin Foà
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 48 Issue 1 Pg. 180-2 (Jan 2007) ISSN: 1042-8194 [Print] United States
PMID17325863 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Thalidomide
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors (adverse effects, therapeutic use)
  • Female
  • Humans
  • Leukemia, Plasma Cell (diagnosis, drug therapy, mortality)
  • Male
  • Maximum Tolerated Dose
  • Middle Aged
  • Multiple Myeloma (diagnosis, drug therapy, mortality)
  • Prognosis
  • Salvage Therapy
  • Survival Analysis
  • Thalidomide (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: